The objective of the study was to determine whether the temperature of urine samples from patients with prostate cancer or the temperature of urine samples from men not suffering from this condition affects the efficacy of prostate cancer detection performed by a specially trained dog using its olfactory abilities. A total of 218 urine samples, divided into two sets differing in temperature, were tested for male prostate cancer by a dog sniffing urine samples. In group 1 (urine temperature 15–23 °C), 120 urine samples were examined by a sniffer dog, of which 57 samples were positive (from the group of men with established prostate cancer) and 63 samples were negative (from men not affected by prostate cancer). In group 2 (urine temperature 2–14 °C), 98 urine samples were examined by a sniffer dog, of which 51 were positive (from the group of men with established prostate cancer) and 47 were negative (from men not affected by prostate cancer). The results of our study demonstrated no link between the efficacy of male prostate cancer detection performed by a specially trained dog using its olfactory abilities from a urine sample and the temperature range from 2–23 °C (P > 0.05).
Intervertebral disc extrusion (IVDE) is a common neurological condition in many dog breeds. This study aimed to describe this condition in Yorkshire terriers (YT) and calculate the prevalence of this condition amongst the YTs with neurological diseases. This is a double-centre retrospective study which was conducted in two arms. The first part of the study, describing the clinical features and prognosis of cervical (C) IVDE in YTs, is based on data from 2005 to 2021. The second part of the study calculated the prevalence of C IVDE amongst the YTs with neurological diseases based on data from 2016 to 2021. A retrospective search through the medical records was conducted. YTs with C IVDE diagnosed with MRI and confirmed surgically were eligible for inclusion in this study. Sixty YTs were included in the first part of the study. There were 48 (80%) dogs with acute onset and 12 (20%) with chronic onset with acute deterioration. Ambulation was preserved in 31 (51.7%) dogs on admission, and the remaining 29 (48.3%) dogs were non-ambulatory. No significant association was found between ambulation on admission and recovery status (p = 0.547). Seventy-three intervertebral spaces were treated during the surgical intervention. Relapses were seen in seven (11.7%) dogs. Forty-nine (81.7%) dogs were ambulatory at discharge. A complete recovery was observed in 46 (76.7%) dogs; the remaining dogs (14, 23.3%) were classified as incomplete recovery. A significant difference was found in time to ambulation (p = 0.0238) and time to discharge (p = 0.0139) between the on-admission ambulatory and non-ambulatory dogs. Three hundred and eight YTs were diagnosed with neurological diseases between 2016 and 2021 in one referral centre. C IVDE was diagnosed in 31 (10.06%) dogs. This is the first study explicitly describing the C IVDE in YTs and establishing the prevalence of this condition amongst YTs with other neurological disorders.
- Publikační typ
- časopisecké články MeSH
Protection against water- and air-borne bacteria as well as their detection at very low levels is a big challenge for the health care profession. The study’s main goal was to prepare bacterial filters with a tunable trapping effectivity. We revealed that the trapping efficiency of Escherichia coli estimated from the optical density of bacteria passed through the filter was exponentially dependent on the surface density of the polyacrylonitrile nanofibre membranes. This log/linear regression profile was proven for bacterial trapping efficiency higher than 99.9% which opens a door for easy and tunable constructions of ultrasensitive filters and/or nanosensors as well as for the standardization and quality control of nanofibre membranes.
Biosensors are dynamically developing analytical devices for the detection of substrates or other bioactive substances. They can be used for quick gas or liquid analyses and the construction of sensitive detection systems. This review highlights the advances and development of biosensors suitable for human and veterinary medicine and, namely, a novel contribution of nanotechnology for ultrasensitive diagnosis and personalized medicine. The synergic effect of nanotechnology and biosensors opens a new dimension for effective treatment and disease detection at their early stages.
About 30 percent of patients diagnosed with myelodysplastic syndromes (MDS) progress to acute myeloid leukemia (AML). The senescence of bone marrow?derived mesenchymal stem cells (BMSCs) seems to be one of the determining factors in inducing this drift. Research is continuously looking for new methodologies and technologies that can use bioelectric signals to act on senescence and cell differentiation towards the phenotype of interest. The Radio Electric Asymmetric Conveyer (REAC) technology, aimed at reorganizing the endogenous bioelectric activity, has already shown to be able to determine direct cell reprogramming effects and counteract the senescence mechanisms in stem cells. Aim of the present study was to prove if the anti-senescence results previously obtained in different kind of stem cells with the REAC Tissue optimization - regenerative (TO-RGN) treatment, could also be observed in BMSCs, evaluating cell viability, telomerase activity, p19ARF, P21, P53, and hTERT gene expression. The results show that the REAC TO-RGN treatment may be a useful tool to counteract the BMSCs senescence which can be the basis of AML drift. Nevertheless, further clinical studies on humans are needed to confirm this hypothesis.
MicroRNAs (miRNA) are key regulators of gene expression, controlling different biological processes such as cellular development, differentiation, proliferation, metabolism, and apoptosis. The relationships between miRNA expression and the onset and progression of different diseases, such as tumours, cardiovascular and rheumatic diseases, and neurological disorders, are well known. A nanotechnology-based approach could match miRNA delivery and detection to move beyond the proof-of-concept stage. Different kinds of nanotechnologies can have a major impact on the diagnosis and treatment of miRNA-related diseases such as cancer. Developing novel methodologies aimed at clinical practice represents a big challenge for the early diagnosis of specific diseases. Within this context, nanotechnology represents a wide emerging area at the forefront of research over the last two decades, whose potential has yet to be fully attained. Nanomedicine, derived from nanotechnology, can exploit the unique properties of nanometer-sized particles for diagnostic and therapeutic purposes. Through nanomedicine, specific treatment to counteract only cancer-cell proliferation will be improved, while leaving healthy cells intact. In this review, we dissect the properties of different nanocarriers and their roles in the early detection and treatment of cancer.
- MeSH
- lidé MeSH
- mikro RNA * metabolismus MeSH
- nádory * diagnóza genetika terapie MeSH
- nanomedicína MeSH
- nanotechnologie metody MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Dead space after rectal resection in colorectal surgery is an area with a high risk of complications. In this study, our goal was to develop a novel 3D implant based on composite hydrogels enriched with fractionalized nanofibers. We employed, as a novel approach in abdominal surgery, the application of agarose gels functionalized with fractionalized nanofibers on pieces dozens of microns large with a well-preserved nano-substructure. This retained excellent cell accommodation and proliferation, while nanofiber structures in separated islets allowed cells a free migration throughout the gel. We found these low-concentrated fractionalized nanofibers to be a good tool for structural and biomechanical optimization of the 3D hydrogel implants. In addition, this nano-structuralized system can serve as a convenient drug delivery system for a controlled release of encapsulated bioactive substances from the nanofiber core. Thus, we present novel 3D nanofiber-based gels for controlled release, with a possibility to modify both their biomechanical properties and drug release intended for 3D lesions healing after a rectal extirpation, hysterectomy, or pelvic exenteration.
- Publikační typ
- časopisecké články MeSH
PURPOSE OF THE STUDY Tendon injuries continue to be a highly topical issue. Research and clinical activities in this area aim to achieve an optimal repair of the damaged tendon. Such suture is characterised by maximum tensile strength, resistance to gapping at the repair site, preservation of smooth surface, prevention of adhesions and facilitation of fast rehabilitation and active tendon movement. The suture as such is required to show mechanical resistance in particular. Considered optimal is the use of core suture of the tendon in combination with epitendinous suture. The group of researchers has for several years already been exploring new materials. They can contribute to better balance between adequate mechanical strength of the suture and biological support of healing. MATERIAL AND METHODS The study was carried out as an ex vivo experiment on porcine tendon models. A tendon segment was obtained from slaughtered animals and a total rupture of the tendon was imitated by sharp cutting of its central portion. Subsequently, the tendon was repaired by Adelaide suture using coated braided polyester (Ethibond) and two types of new polyamide 6 based (PA6) sutures. The first suture was designed as an unabsorbable polyester core (PES silk) surrounded by absorbable PA6 nanofibres. The second suture was created by braiding a PES silk yarn and two viscose yarns with PA6 nanofibres into a composite surgical suture. As a part of the study also examined was the tensile strength of suture with the use of other stitches, effect of the shape of the needle s point on the tensile strength of the suture and the effect of secured mattress peritendinous suture. The tensile strength of the suture was tested until failure and the achieved maximum load was monitored. RESULTS The PES core yarn with PA6 nanofibre braiding showed lower tensile strength (28.5 ± 5.2 N) than the yarn braided from one PES yarn and two viscose yarns with PA6 nanofibres (45.7 ± 6.7 N). Both newly developed sutures, however, fail to achieve the tensile strength of Ethibond (100.3 ± 19.1 N). In case of Ethibond suture using various types of stitches, the lowest tensile strength was observed in McLarney 4-strand core suture (68.8 ± 18.7 N). A higher tensile strength was achieved by Adelaide 4-strand core suture (83.6 ± 11.2 N). The highest tensile strength was seen in 6-strand core Savage suture (147.4 ± 22.7 N). When the effect of the type of needle was tested, a statistically significant difference between the taper point needle (72.0 ± 7.0 N) and reverse cutting needle (63.3 ± 9.6 N) was observed. In case of McLarney suture the epitendinous stitch increased the tensile strength by 46.2% and in case of Adelaide suture by 48.3%. CONCLUSIONS For tendon core suture, the use of sutures with multiple longitudinal segments seems more appropriate. The epitendinous suture can considerably reinforce the basic load-bearing core suture. Also observed was not an insignificant effect of the needle profile on the resulting tensile strength of the suture. In materials developed by us, more suitable seems to be the design of braiding of absorbable nanofibers with a load-bearing non-absorbable yarn. While the mechanical tensile strength of new materials is lower, the benefits are expected in the form of biological support of healing. Moreover, the nanofibers can be used as a carrier of biological and therapeutic substances. Further improvement of mechanical properties of the newly developed biomaterial can be foreseen if the material of the load-bearing non-absorbable yarn is changed or the load-bearing yarn and nanofibres ratio modified. This pilot study shall use the findings for further development and modification of new materials in basic research and shall also verify the biological aspects and the course of healing in in vivo studies. Key words: tendon, suture, pig, biomaterials, nanofibres, mechanical testing, healing, polyester, Adelaide.
- MeSH
- biokompatibilní materiály * MeSH
- biomechanika MeSH
- lidé MeSH
- pilotní projekty MeSH
- prasata MeSH
- šicí techniky MeSH
- šlachy * chirurgie MeSH
- sutura MeSH
- testování materiálů MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Závěrečná zpráva o řešení grantu Agentury pro zdravotnický výzkum MZ ČR
Nestr.
Replacing damaged tissue from the musculoskeletal system is a topical issue in biomedical technology. This project looks at the development of new biomaterials and functionalized nanofibres (to be combined with stem cells and growth factors), including new surgical techniques to treat severe traumas of the musculoskeletal system by transplanting these biomaterials into large bone defects, injured ligaments and tendons. The project team was formed as part of NPV II, VZ, IGA MZ and provides a long-term dynamic, stable, multidisciplinary, well-structured and productive research team with a high capacity for creativity, using the most advanced facilities and apparatus. The project is designed in such a way that the experimental development and preclinical testing of biomaterials using suitable animal models resulted in technology which guarantees their safe use as replacements for irreversibly damaged human tissue. When introducing new treatment methods, these steps are essential prior to the actual clinical trials and the possible introduction of new products into clinical practice.
V biomedicínských technologiích je velmi aktuální problematika náhrad tkání poškozeného pohybového aparátu. Projekt je zaměřen na vývoj zcela nových biomateriálů a funkcionalizovaných nanovláken (pro kombinaci s kmenovými buňkami a růstovými faktory), včetně nových chirurgických technik léčby závažných traumat pohybového aparátu v podobě transplantací těchto biomateriálů do rozsáhlých defektů kostí a poraněných vazů a šlach. Řešitelský tým byl vybudován v rámci úspěšného řešení NPV II, VZ, IGA MZa dlouhodobě tvoří dynamický, stabilní, multioborový, dobře strukturovanýa produktivní výzkumný tým s vysokou tvůrčí kapacitou, disponující nejmodernějším prostorovým zázemím a špičkovými přístroji. Projekt je koncipován tak, aby experimentální vývoj a preklinické testování biomateriálů u vhodných animálních modelů dospěly k technologiím, jež by zaručily jejich bezpečné použití jakožto náhrad ireverzibilně poškozených tkání člověka. Tyto kroky jsou při zavádění nových léčebných metod nezbytné ještě před vlastními klinickými zkouškamia případným zavedením nových produktů do klinické praxe.
- MeSH
- biokompatibilní materiály terapeutické užití MeSH
- hojení ran MeSH
- kosti a kostní tkáň zranění MeSH
- lidé MeSH
- ligamenta zranění MeSH
- modely nemocí na zvířatech MeSH
- nanokompozity terapeutické užití MeSH
- řízená tkáňová regenerace metody MeSH
- šlachy patologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- NLK Publikační typ
- závěrečné zprávy o řešení grantu AZV MZ ČR
BACKGROUND: Nivolumab is a human monoclonal antibody against programmed cell death receptor-1 (PD-1) able to rescue quiescent tumor infiltrating cytotoxic T lymphocytes (CTLs) restoring their ability to kill target cells expressing specific tumor antigen-derived epitope peptides bound to homologue human leukocyte antigen (HLA) molecules. Nivolumab is currently an active but expensive therapeutic agent for metastatic non-small cell lung cancer (mNSCLC), producing, in some cases, immune-related adverse events (irAEs). At the present, no reliable biomarkers have been validated to predict either treatment response or adverse events in treated patients. METHODS: We performed a retrospective multi-institutional analysis including 119 patients with mNSCLC who received PD-1 blockade since November 2015 to investigate the predictive role of germinal class I HLA and DRB1 genotype. We investigated the correlation among patients' outcome and irAEs frequency with specific HLA A, B, C and DRB1 alleles by reverse sequence-specific oligonucleotide (SSO) DNA typing. RESULTS: A poor outcome in patients negative for the expression of two most frequent HLA-A alleles was detected (HLA: HLA-A*01 and or A*02; progression-free survival (PFS): 7.5 (2.8 to 12.2) vs 15.9 (0 to 39.2) months, p=0.01). In particular, HLA-A*01-positive patients showed a prolonged PFS of 22.6 (10.2 to 35.0) and overall survival (OS) of 30.8 (7.7 to 53.9) months, respectively. We also reported that HLA-A and DRB1 locus heterozygosis (het) were correlated to a worse OS if we considered het in the locus A; in reverse, long survival was correlated to het in DRB1. CONCLUSIONS: This study demonstrate that class I and II HLA allele characterization to define tumor immunogenicity has relevant implications in predicting nivolumab efficacy in mNSCLC and provide the rationale for further prospective trials of cancer immunotherapy.
- MeSH
- alely MeSH
- analýza přežití MeSH
- HLA antigeny metabolismus MeSH
- inhibitory kontrolních bodů farmakologie terapeutické užití MeSH
- lidé MeSH
- nádory plic genetika mortalita MeSH
- nemalobuněčný karcinom plic genetika mortalita MeSH
- retrospektivní studie MeSH
- senioři MeSH
- výsledek terapie MeSH
- zárodečné mutace genetika MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
